AzTrials
AzTrials

Adjustment DisordersNCT04797273

Internet-based CBT vs. TAU for Stress-related Disorders

A study testing Internet-based cognitive behavior therapy and Internet-based structured treatment-as-usual in people with Adjustment Disorders and Exhaustion Disorder, run by Karolinska Institutet at 1 site in Sweden.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Stress-related mental illness is common and one of the main causes of sick leave in Sweden. Cognitive behavior therapy (CBT) is a promising treatment, but access to treatment is low. Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Adjustment Disorders, Exhaustion Disorder
What is being tested?
Internet-based cognitive behavior therapy and Internet-based structured treatment-as-usual
Could I receive a placebo?
No, everyone receives an active treatment
How many people
300 participants
Where
1 siteSweden
Study dates
25 Mar 2021to 1 Jun 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • primary adjustment disorder or exhaustion disorder
  • regular access to a computer and to the internet
  • ability to read and write in swedish

Who cannot join

  • substance abuse in the past 6 months
  • lifetime psychosis or bipolar disorder
  • suicide risk
  • initiated or changed psychopharmacological treatment for depression or anxiety in the past month
  • concurrent psychological treatment
  • cognitive behavior therapy for stress-related symptoms in the past year.

Trial locations and contacts

1 site in 1 country.

Sweden1 site
  • Gustavsbergs Primary Care Center

    Gustavsberg, Stockholm County, 13440

Other trials in Sweden

About this study

Official title: Internet-based Cognitive Behavior Therapy for Stress-related Disorders

Stress-related mental illness is common and one of the main causes of sick leave in Sweden. Cognitive behavior therapy (CBT) is a promising treatment, but access to treatment is low. In a previously conducted study, we found that internet-based CBT in comparison to a waitlist control group was effective in reducing symptoms of stress. The aim of the present study is to take the next step and compare Internet-based CBT for stress-related disorders to an active control condition.

Read the detailed description

Non traumatic stress-related mental illness, in this study operationalized as adjustment disorder or exhaustion disorder, is highly prevalent in the general population and associated with high societal costs relating to productivity loss. Cognitive behavior therapy (CBT) is the most well-studied psychological treatment and has demonstrated promising effects in terms of symptom reduction. The overall evidence-base for CBT for these disorders is however fairly week and access to treatment is low. In a previously published randomized controlled trial we found that internet-based CBT can yield large effects on core symptoms of stress for these disorders. Delivering CBT via the internet has the large advantage of enabling increased accessibility as each therapist can have up to 80 patients in ongoing treatment. In the previously conducted trial we compared the treatment to a waitlist control and between-group comparisons of treatment effects were only done at post-treatment as the waitlist condition was crossed over to treatment after this time point. It is now therefore important to take the next step and investigate the effects of internet-based CBT in comparison to an active control condition. The primary aim of this study was to compare two internet-based treatments, CBT vs. structured treatment-as-usual, for adjustment disorder and exhaustion disorder.

Being tested
Internet-based cognitive behavior therapy, Internet-based structured treatment-as-usual
Keywords
Internet-based treatment, Randomized controlled trial
Medical subject headings
Adjustment Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Internet-based cognitive behavior therapyBehavioural

    12 week Internet-based cognitive behavior therapy, delivered via an online treatment platform. The treatment includes components such as exercises in conducting recuperating activities, methods to improve sleep, exposure, and behavioral activation. The treatment content is provided through written texts, images and audiofiles in the treatment platform. The participant has access to a therapist who provides support throughout the treatment via asynchronous text messages.

  • Internet-based structured treatment-as-usualBehavioural

    This is a 12-week treatment, delivered via an online treatment platform. The treatment components in this treatment are designed to be similar to what is typically provided in primary care to these patients and includes information about stress and how different factors such as eating habits, physical exercise, and alcohol can contribute to stress problems. The treatment content is provided through written texts, images and audiofiles in the treatment platform. The participant has access to a therapist who provides support throughout the treatment via asynchronous text messages.

Study groups in NCT04797273
Study groupRoleWhat they receive
Internet-based cognitive behavior therapyExperimentalNot described
Receives: Behavioral: Internet-based cognitive behavior therapy
Internet-based structured treatment-as-usualActive comparatorNot described
Receives: Behavioral: Internet-based structured treatment-as-usual

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Perceived Stress Scale (PSS-10)

    Change in PSS at post-treatment and follow-ups compared to baseline (scale range 0-40, higher score means more symptoms)

    Measured: Baseline, weeks 3, 6, 9, 12 (post-treatment), 1-year follow-up, 2-year follow-up

Secondary outcomes (12)
  1. Shirom-Melamed Burnout Questionnaire (SMBQ)

    Change in SMBQ at post-treatment and follow-ups compared to baseline (scale range 1-7, higher score means more symptoms)

    Measured: Baseline, weeks 3, 6, 9, 12 (post-treatment), 1-year follow-up, 2-year follow-up

  2. Montgomery-Åsberg Depression Rating Scale Self-report (MADRS-S)

    Change in MADRS-S at post-treatment and follow-ups compared to baseline (scale range 0-54, higher score means more symptoms)

    Measured: Baseline, week 12 (post-treatment), 1-year follow-up, 2-year follow-up

  3. Insomnia Severity Index (ISI)

    Change in ISI at post-treatment and follow-ups compared to baseline (scale range 0-28, higher score means more symptoms)

    Measured: Baseline, weeks 3, 6, 9, 12 (post-treatment), 1-year follow-up, 2-year follow-up

  4. Generalized Anxiety Disorder-7 (GAD-7)

    Change in GAD-7 at post-treatment and follow-ups compared to baseline (scale range 0-21, higher score means more symptoms)

    Measured: Baseline, week 12 (post-treatment), 1-year follow-up, 2-year follow-up

  5. Sickness Questionnaire (SQ)

    Change in SQ at post-treatment and follow-ups compared to baseline (scale range 0-30, higher score means more symptoms)

    Measured: Baseline, week 12 (post-treatment), 1-year follow-up, 2-year follow-up

  6. Self-rated Health (SRH)

    Change in SRH at post-treatment and follow-ups compared to baseline (scale range 1-5, higher score means better self-rated health)

    Measured: Baseline, week 12 (post-treatment), 1-year follow-up, 2-year follow-up

  7. World Health Organization's Disability Assessment Scale (WHODAS 2.0)

    Change in WHODAS at post-treatment and follow-ups compared to baseline (scale range 0-100, higher score means more functional disability)

    Measured: Baseline, week 12 (post-treatment), 1-year follow-up, 2-year follow-up

  8. EuroQol 5D (EQ5D 5L)

    Change in EQ5D at post-treatment and follow-ups compared to baseline (The answers given in EQ-5D were combined to generate a utility score of health states ranging from 0 to 1, with 0 representing death and 1 representing full health) death and 1 representing full health

    Measured: Baseline, week 12 (post-treatment), 1-year follow-up, 2-year follow-up

  9. Trimbos and Institute Medical Technology Assessment of Costs Questionnaire for Psychiatry (TIC-P)

    The TIC-P enables estimation of costs by collecting information about participant resource utilization and costs related to production loss. Change in costs will be analysed at post-treatment and follow-ups compared to baseline.

    Measured: Baseline, week 12 (post-treatment), 1-year follow-up, 2-year follow-up

  10. Physical Health Questionnaire (PHQ-15)

    Change in PHQ-15 at post-treatment and follow-ups compared to baseline (scale range 0-30, higher score means more symptoms)

    Measured: Baseline, week 12 (post-treatment), 1-year follow-up, 2-year follow-up

  11. Cognitive impairment

    Test-battery of cognitive tests measuring executive functions at post-treatment and follow-ups compared to baseline

    Measured: Baseline, week 12 (post-treatment), 1-year follow-up, 2-year follow-up

  12. Sick leave

    Sick leave data from the Microdata for Analysis of Social Security (MiDAS) registry. Analyzed as full-day equivalents.

    Measured: 1 year prior to baseline up to 2 years after baseline.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Mar 2021
  2. Study start25 Mar 2021
  3. Primary completion1 Jun 2024
  4. Study completion1 Jun 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
300 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04797273
Sponsor's protocol ID
ICBT vs TAU for Stress
Status last verified
Sep 2025
First submitted
11 Mar 2021
Last updated
15 Sep 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Sennerstam V, Franke Foyen L, Kontio E, Svardman F, Lekander M, Lindsater E, Hedman-Lagerlof E. Internet-Delivered Treatment for Stress-Related Disorders: A Randomized Controlled Superiority Trial of Cognitive Behavioral Therapy versus General Health Promotion. Psychother Psychosom. 2025;94(4):273-288. doi: 10.1159/000546221. Epub 2025 May 7.

    PubMed 40334656
  • Franke Foyen L, Sennerstam V, Kontio E, Lekander M, Hedman-Lagerlof E, Lindsater E. Objective cognitive functioning in patients with stress-related disorders: a cross-sectional study using remote digital cognitive testing. BMC Psychiatry. 2023 Aug 7;23(1):565. doi: 10.1186/s12888-023-05048-5.

    PubMed 37550693

Questions about this trial

What is this clinical trial studying?

A study testing Internet-based cognitive behavior therapy and Internet-based structured treatment-as-usual in people with Adjustment Disorders and Exhaustion Disorder, run by Karolinska Institutet at 1 site in Sweden.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 15 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Perceived Stress Scale (PSS-10) (time frame: Baseline, weeks 3, 6, 9, 12 (post-treatment), 1-year follow-up, 2-year follow-up). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04797273, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Sep 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in